The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term results of a phase I/II trial of nelfinavir with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.
 
Ramesh Rengan
Consulting or Advisory Role - AstraZeneca
 
Rosemarie Mick
Stock and Other Ownership Interests - Editas Medicine
Consulting or Advisory Role - Infiniti Medical
 
Daniel Pryma
No Relationships to Disclose
 
Lilie L. Lin
No Relationships to Disclose
 
John Paul Christodouleas
Employment - Elekta
 
John Peter Plastaras
Travel, Accommodations, Expenses - IBA
 
Charles B. Simone
No Relationships to Disclose
 
Anjali K. Gupta
No Relationships to Disclose
 
Tracey L. Evans
Honoraria - Genentech; Genentech (I)
Consulting or Advisory Role - Genentech; Genentech (I)
Speakers' Bureau - Genentech (I)
Travel, Accommodations, Expenses - Celgene; Genentech; Genentech (I)
 
James Stevenson
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Takeda
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst)
Other Relationship - Amgen; Lilly; Peregrine Pharmaceuticals; Synta
 
John Kucharczuk
No Relationships to Disclose
 
Joseph S. Friedberg
Patents, Royalties, Other Intellectual Property - multiple inventions related to medical devices. none have earned any income or are currently slated to do so. (Inst)
 
Sarah Lam
No Relationships to Disclose
 
Dana Patsch
No Relationships to Disclose
 
Stephen M. Hahn
No Relationships to Disclose
 
Amit Maity
Research Funding - Merck (Inst)